COVID-19 pandemic in the Andaman and Nicobar Islands

Last updated

COVID-19 pandemic in the Andaman and Nicobar Islands
Disease COVID-19
Virus strain SARS-CoV-2
Location Andaman and Nicobar Islands, India
First outbreak Wuhan, Hubei, China
Arrival date26 March 2020
(5 years, 3 months, 3 weeks and 2 days)
Confirmed cases6,398 (10 May 2021)
Active cases195
Recovered6,125 (10 May 2021)
Deaths
78 (10 May 2021)
Fatality rate1.22%
Territories

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Andaman and Nicobar Islands. The first case was recorded in this region on 26 March 2020. [1] The islands have pursued a strategy of zero COVID-19 transmission, which, except for three flareups in August 2020, May 2021, and January 2022, which were swiftly contained, have resulted in no community outbreaks. The islands have successfully managed the outbreaks, and the union territory has the lowest case count of any region of India, both in total cases and infection rate. [2]

Contents

Timeline

May 2020

June 2020

July 2020

August 2020

September 2020

October 2020

November 2020

December 2020

January 2021

February 2021

March 2021

April 2021

May 2021

June 2021

July 2021

August 2021

September 2021

Oct to Dec 2021

Jan to Mar 2022

Apr to Jun 2022

July to September 2022

COVID-19 Vaccines with Approval for Emergency or Conditional Usage

Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021. The Union Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021 (2).jpg
Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021.

Covishield

On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield). [5] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech. [6] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India. [7]

Covaxin

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage. [8]

On 14 January 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing. [9]

Others

On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG. [10] On 21 February 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age. [11] [12]

On 21 October 2021, India completed administering of one billion Covid vaccines in the country. [13]

On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country. [14]

On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country. [15]

See also

References

  1. Roy A, Jahnavi G, Peter S, Dakuya TK, Venugopal V, Bhattacharya S, Biswas B (29 November 2024). "Difference in the epidemiological and clinical profiles of mortality between the first and second waves of COVID-19 pandemic in a tertiary care hospital of Andaman and Nicobar Islands". J Educ Health Promot. 13: 433. doi: 10.4103/jehp.jehp_1887_23 . PMC   11731239 . PMID   39811844.
  2. "#IndiaFightsCorona COVID-19". 16 March 2020.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 "MoHFW-GOI". Ministry of Health and Family Welfare . Retrieved 23 May 2020.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 "COVID19 STATEWISE STATUS". MyGov.in. 28 March 2020. Retrieved 4 December 2021.
  5. "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 4 January 2021.
  6. "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 4 January 2021.
  7. "Stand By, India: Serum Institute Sends Out Vaccines, 1st Batch In Delhi". NDTV. 12 January 2021. Retrieved 12 January 2021.
  8. "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 4 January 2021.
  9. "Covaxin delivery starts, 'full initial procurement allotted'". Indian Express. 14 January 2021. Retrieved 14 January 2021.
  10. "Dr Reddy's confirms Emergency Use Authorisation for anti-COVID drug 2-DG, says price not yet fixed". Moneycontol. 19 May 2021. Retrieved 20 May 2021.
  11. "Approval granted to COVID vaccine Corbevax for children between 12-18 years". Times of India. 21 February 2022. Retrieved 22 February 2022.
  12. "Biological E's Covid vaccine Corbevax receives emergency use nod for children aged 12-18 yrs". Hindustan Times. 21 February 2022. Retrieved 22 February 2022.
  13. "India scripts history, administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021.
  14. "India crosses 1.5 bn Covid vaccine doses, Modi terms it 'significant milestone'". Hindustan Times. 9 January 2022. Retrieved 9 January 2022.
  15. "COVID-19: India's vaccination coverage crosses 175 crore mark". DNA India. 19 February 2022. Retrieved 26 February 2022.